Sort
82,697 grants matching “vaccine development”
Heat Shock Protein and Thermal Therapy of Cancer
$1,349,240Roswell Park Cancer Institute Corp · P01 · FY2004 · CA
Task X19: Development of Assays and Reagents for Zika Virus Vaccines
$1,349,169Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2018 · AI
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,348,882David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2016 · AI
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,348,882David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2018 · AI
Flavivirus Infections: Pathogenesis and Prevention
$1,348,663Univ Of Massachusetts Med Sch Worcester · P01 · FY2003 · AI
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,348,462Kenner Rice · National Institute On Drug Abuse · ZIA · FY2017 · DA
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,348,156Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,348,022Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION
$1,347,763Marx Preston · Tulane University Of Louisiana · N01 · FY2016 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2020 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2019 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2021 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2022 · AI
Influenza Viral Pathogenesis
$1,347,530Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
San Francisco Bay Clinical Trials Unit (CTU)
$1,347,336Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2021 · AI
Immunity to Pneumonic Tularemia
$1,347,335Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Preclinical Studies of Bunyaviruses
$1,347,089Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Core A: Husbandry & Management Core
$1,346,834Cassandra Cullin · Oregon Health & Science University · U42 · FY2024 · OD
Host-Tumor Cell Interactions in Myeloma:
$1,346,410Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,346,111Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
IND-enabling Preclinical Studies for Aβ and Dual Aβ/Tau MultiTEP platform-based AD Vaccines
$1,346,072Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2021 · AG
Pediatric AIDS Clinical Trials Unit
$1,345,731Children'S Memorial Hospital (Chicago) · U01 · FY2002 · AI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
$1,345,576Alon Herschhorn · University Of Minnesota · U01 · FY2025 · AI
Control of Epidemic Influenza
$1,345,512Baylor College Of Medicine · R01 · FY2004 · AI
Optimization of HIV glycoproteins as vaccine candidates
$1,345,369Jose A Lasalde-Dominicci · University Of Puerto Rico · R01 · FY2017 · AI